William R. Elder - 14 May 2025 Form 4 Insider Report for CervoMed Inc. (CRVO)

Reporting relationship: CFO, GC & Secretary
Issuer ticker: CRVO
Reported as of: 14 May 2025
Net transaction value: +$35,811
SEC form: 4
Accepted by SEC: 14 May 2025, 16:11:47 UTC
Prior SEC filing: 14 Feb 2025
Next SEC filing: 13 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ William R. Elder

Key filing fact

William R. Elder filed Form 4 for CervoMed Inc. (CRVO) on 14 May 2025.

Key facts

This page summarizes William R. Elder's Form 4 filing for CervoMed Inc. (CRVO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 May 2025, 16:11.

Change

Previous filing in this sequence was filed on 14 Feb 2025.
Current net transaction value: +$35,811.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001828068 Primary reporting owner

ELDER WILLIAM ROBERT

Relationship: CFO, GC & Secretary
Address: 20 PARK PLAZA, SUITE 424, BOSTON
Signature: /s/ William R. Elder
Signature date: 14 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRVO transaction

Common Stock

Purchase

Transaction value: $35,811
Shares: +4,233
Change %: +334%
Price: $8.46
Shares after: 5,500
Date: 14 May 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Shares purchased in open-market transactions.

Footnote F2

Represents weighted average price of (i) 3,800 shares purchased at $8.4499 per share and (ii) 433 shares purchased at $8.5373 per share.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .